ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3001

Lumbar CT-Guided Steroid Infiltration on the Refractory Low Back Pain. Study of 258 Procedures in the Same Center

Eva Galindez Agirregoikoa1, Olaia Fernandez Berrizbeitia1, M. Luz García Vivar2, Esther Ruíz Lucea2, Jose Francisco Garcia Llorente2, Ignacio Torre Salaberri3, Catalina Gómez Arango2, Juan Maria Blanco Madrigal2, Edurne Guerrero Basterretxea1, Itziar Calvo Zorrilla1, Natalia Garcia Rivera1 and Maria Jesus Allande Lopez Linares1, 1Rheumatology Department, Basurto University Hospital, Bilbao, Spain, 2Rheumatology, Rheumatology Department, Basurto University Hospital, Bilbao, Spain, 3Rheumaytology, Rheumatology Department, Basurto University Hospital, Bilbao, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Low back pain and treatment

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Orthopedics, Low Back Pain and Rehabilitation

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Low back pain of mechanical origin is a major cause of disability and surgical intervention. The lumbar computed tomography (CT)-guided steroid infiltration can accelerate the recovery process and sometimes avoid the surgery. Our aim was to review the indications, efficacy and complications of this technique in a wide series of unselected patients. In addition a comparative study of efficacy was performed according to the lumbar underlying pathology, type of steroid and approach of injection.

Methods: Study of lumbar CT-guided steroid injections performed in a University Hospital between January 2012 and June 2015. The minimum follow-up was 3 months. The procedure was performed in patients with low back pain refractory to standard medical therapy and Lumbar Spine Rehabilitation. Efficacy was assessed at 1 and 3 months according to a semiquantitative scale as the pain response as a) total response, b) partially c) no or d) worsening pain. A comparative study of the efficacy and safety was performed, regarding: a) underlying pathology, b) approach of injection and c) the different types of steroids used. Fisher’s test and Chi2 and the SAS System for Windows V program 9.2.were used for statistical analysis.

Results: During the study period 258 procedures were performed in 171 patients (132 men / 126 women) with a mean age ± SD of 58.24±13.45 years (range, 18-88). The indications for the injection were: a) disc herniation (44.57%), b) lumbar stenosis (34.11%), c) postoperative fibrosis and spondylolisthesis (20.15%) and d) facet joint synovial cysts syndrome (1.17%). Approaches used were: a) posterior epidural (24.42%), b) lateral recess (58.91%), and c) foraminal (16.67%). The chosen steroid was triamcinolone (74.81%), dexamethasone (23.64%) and methylprednisolone (1.55%). In a significant proportion of the procedures improvement in the patient´s sintomatology was reported at the first month, regardless of the indication, route of corticosteroid injection and steroid used (TABLE). Regarding the overall outcome, at 3 months 72.48% of the patients experienced clinical improvement. And only 21.71% of patients required a subsequent surgery. The clinical efficacy showed no statistically significant differences according to the indication of the procedure or the route used for the injection. However, the improvement of pain was significantly greater in patients treated with triamcinolone than those treated with dexamethasone (p = 0.01). Regarding safety there were 6 (2.3%) local complications (puncture of the thecal sac) and 3 (1.16%) systemic complications (allergic reaction). None of these complicationes were of clinical relevance and they were not associated with the corticosteroid used.

Conclusion:  CT-guided corticosteroid injection is an effective and safe treatment in low back pain refractory to standard medical therapy in patients with spinal stenosis, disc herniation and postoperative fibrosis. Triamcinolone infiltration seems to be more effective than dexamethasone.


Disclosure: E. Galindez Agirregoikoa, None; O. Fernandez Berrizbeitia, None; M. L. García Vivar, None; E. Ruíz Lucea, None; J. F. Garcia Llorente, None; I. Torre Salaberri, None; C. Gómez Arango, None; J. M. Blanco Madrigal, None; E. Guerrero Basterretxea, None; I. Calvo Zorrilla, None; N. Garcia Rivera, None; M. J. Allande Lopez Linares, None.

To cite this abstract in AMA style:

Galindez Agirregoikoa E, Fernandez Berrizbeitia O, García Vivar ML, Ruíz Lucea E, Garcia Llorente JF, Torre Salaberri I, Gómez Arango C, Blanco Madrigal JM, Guerrero Basterretxea E, Calvo Zorrilla I, Garcia Rivera N, Allande Lopez Linares MJ. Lumbar CT-Guided Steroid Infiltration on the Refractory Low Back Pain. Study of 258 Procedures in the Same Center [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/lumbar-ct-guided-steroid-infiltration-on-the-refractory-low-back-pain-study-of-258-procedures-in-the-same-center/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lumbar-ct-guided-steroid-infiltration-on-the-refractory-low-back-pain-study-of-258-procedures-in-the-same-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology